Eisai EMEA
Helen Huang is a seasoned professional with extensive experience in pharmacovigilance and drug safety. Currently serving as a Senior PV Operations Scientist at Eisai EMEA since December 2017, Helen has developed a strong expertise in the field. Previously, Helen worked at Eisai from October 2011 to November 2017 in roles including PV Operations Scientist and Drug Safety Associate. Earlier positions include Pharmacovigilance Associate at Akos Limited from May 2010 to August 2011, and a similar role at Schering-Plough Pharmaceuticals from September 2006 to March 2010, where Helen also held the title of EURC Administrator.
This person is not in the org chart
This person is not in any offices
Eisai EMEA
3 followers
At Eisai, everything we do is dedicated to giving our first thought to patients and their families through our human health care (hhc) philosophy. We are the European hub of Tokyo-based Eisai Co. Ltd., forming part of a multinational team working across a global network of R&D facilities, manufacturing sites and marketing subsidiaries. Our collective passion and dedication to patient care is the driving force behind our efforts to discover and develop innovative medicines in a variety of therapeutic areas in which a high unmet medical need remains, including oncology and neurology. Our mission is clear; we strive to make a significant long-lasting contribution to society in an ethical, compliant and sustainable way by embodying our hhc philosophy in everything we do. For more information about Eisai in the EMEA region please visit www.eisai.eu Our community guidelines can be found here: https://www.eisai.eu/wp-content/uploads/Community-guidelines-v1.0.pdf For more information about how Eisai processes your data, please refer to our privacy policy here: https://www.eisai.eu/privacy-policy/ --- November 2023 | EMEA-NON-23-00180